FRANCES NARVAIZ: Open Payments
NPI 1376046532 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,056 in 73 payments from 21 companies in 2025. Trend: 2023 $179 · 2024 $1,458 · 2025 $2,056
Food & beverage: $2,056
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 30 | $848 |
| Abbott Laboratories | 5 | $398 |
| Lilly USA, LLC | 11 | $151 |
| Janssen Biotech, Inc. | 1 | $144 |
| Merck Sharp & Dohme LLC | 3 | $58 |
| PFIZER INC. | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 3 | $52 |
| Medtronic, Inc. | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Hologic Sales and Service, LLC | 1 | $37 |
Products named: FREESTYLE LIBRE 3, Ozempic, Rybelsus, Wegovy, MOUNJARO, RYBREVANT, GARDASIL 9, PREVNAR 20.
Industry payments across TX — which companies pay providers there.
